Macrocyclic compounds useful as pharmaceuticals

Details for Australian Patent Application No. 2003224672 (hide)

Owner Eisai R&D Management Co., Ltd.

Inventors Harmange, Jean-Christophe; Shirota, Hiroshi; Tanaka, Isao; Muramoto, Kenzo; Kuboi, Yoshikazu; Du, Hong; Lemelin, Charles-Andre; Shen, YongChun; Kimura, Akifumi; Boivin, Roch; Spyvee, Mark; Kawada, Megumi; Wang, John (Yuan); Fujita, Masanori; Gusovsky, Fabian; Kawai, Takatoshi; Sakurai, Hideki; Eguchi, Yoshihito; Goto, Masaki; Kawakami, Yoshiyuki; Mizui, Yoshiharu; Yamamoto, Satoshi; Jiang, Yimin; Matsushima, Tomohiro; Li, Xiang-Yi; Yoneda, Naoki; Chow, Jesse; Inoue, Atsushi; Kotake, Makoto; Chiba, Kenichi

Agent Davies Collison Cave

Pub. Number AU-B-2003224672

PCT Number PCT/US03/07377

PCT Pub. Number WO2003/076424

Priority 60/380,711 14.05.02 US; 60/362,883 08.03.02 US

Filing date 7 March 2003

Wipo publication date 22 September 2003

Acceptance publication date 4 February 2010

International Classifications

C07D 491/044 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

A61K 31/335 (2006.01) - having oxygen as the only ring hetero atom, e.g. fungichromin

A61K 31/36 (2006.01)

A61K 31/365 (2006.01) - Lactones

A61K 31/395 (2006.01) - having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins

A61K 31/4178 (2006.01)

A61K 31/4188 (2006.01)

A61K 31/5377 (2006.01)

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 7/04 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 11/02 (2006.01) Drugs for disorders of the respiratory system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 17/04 (2006.01) Drugs for dermatological disorders

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 17/16 (2006.01) Drugs for dermatological disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 19/04 Drugs for skeletal disorders

Event Publications

7 August 2003 Complete Application Filed

  Priority application(s): 60/380,711 14.05.02 US; 60/362,883 08.03.02 US

30 October 2003 Application Open to Public Inspection

  Published as AU-B-2003224672

6 December 2007 Assignment before Grant

  Eisai Co. Ltd The application has been assigned to Eisai R&D Management Co., Ltd.

4 February 2010 Application Accepted

  Published as AU-B-2003224672

3 June 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003224673-METHODS AND SYSTEMS FOR MODELING AND USING COMPUTER RESOURCES OVER A HETEROGENEOUS DISTRIBUTED NETWORK USING SEMANTIC ONTOLOGIES

2003224671-PREPARATIVE SEPARATION OF MIXTURES BY MASS SPECTROMETRY